Press releases

December 12, 2018

Press release - Regulatory

Targovax Presents at DNB 9th Annual Nordic Healthcare Conference

November 28, 2018

Press release - Non-regulatory

Targovax is invited to present at upcoming investor and industry conferences

November 16, 2018

Press release - Non-regulatory

Targovax to present at NeoAg Summit 2018

November 1, 2018

Press release - Regulatory

Targovax ASA: Third quarter 2018 results

October 26, 2018

Press release - Regulatory

Targovax ASA: Announcement of third quarter 2018 financial results

October 15, 2018

Press release - Non-regulatory

Targovax reports encouraging disease-free survival (DFS) data from TG01 trial in resected pancreatic cancer

October 12, 2018

Press release - Regulatory

Agenda for Targovax Capital Markets Day 15 October 2018, in Oslo, Norway

October 11, 2018

Press release - Regulatory

Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City today, 11 October, 2018

October 4, 2018

Press release - Regulatory

Targovax to host Capital Markets Day 15 October 2018, in Oslo, Norway

October 1, 2018

Press release - Regulatory

Targovax presented ONCOS-102 poster at 13th International Adenovirus Meeting

September 27, 2018

Press release - Regulatory

Targovax announces interim results from Phase I trial of ONCOS-102 in checkpoint inhibitor refractory melanoma

September 27, 2018

Press release - Regulatory

Targovax to Host Key Opinion Leader Symposium on Oncolytic Viruses in New York City, 11 October 2018

September 25, 2018

Press release - Regulatory

Targovax ASA: Issuance of options to primary insider

September 13, 2018

Press release - Regulatory

Targovax strengthens management team with the appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO

September 12, 2018

Press release - Regulatory

Targovax announces publication of new oncolytic virus data in the Journal of Medical Virology and Cancer Gene Therapy

September 4, 2018

Press release - Regulatory

Targovax ASA: Registration of new share capital following settlement of restricted stock units

August 29, 2018

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

August 23, 2018

Press release - Regulatory

Targovax ASA: Second quarter and first half year 2018 results

August 15, 2018

Press release - Regulatory

Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August

July 12, 2018

Press release - Regulatory

Targovax and SOTIO announce first patient dosed in Phase I/II combination trial of ONCOS-102 with DCVAC

June 20, 2018

Press release - Regulatory

Targovax ASA: Mandatory notification of trade – primary insider

June 19, 2018

Press release - Regulatory

Targovax granted EU Patent for mutant-RAS neoantigen platform 2nd generation product TG02

June 12, 2018

Press release - Regulatory

Targovax hosts conference call 12 June 2018

June 11, 2018

Press release - Regulatory

Targovax strengthens focus on ONCOS oncolytic virus development program

June 4, 2018

Press release - Regulatory

Targovax to Present at Jefferies 2018 Global Healthcare Conference

May 24, 2018

Press release - Regulatory

Targovax strengthens 2-year survival rate in resected pancreatic cancer with TG01

May 16, 2018

Press release - Regulatory

Targovax to present at upcoming investor and industry conferences

May 3, 2018

Press release - Regulatory

Targovax ASA: First quarter 2018 results

May 2, 2018

Press release - Regulatory

Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma

April 25, 2018

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

April 25, 2018

Press release - Non-regulatory

Targovax presentation at ChinaBio Partnering Forum 2018

April 24, 2018

Press release - Regulatory

Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May

April 12, 2018

Press release - Regulatory

Targovax strengthens Board of Directors with the appointment of Catherine Wheeler

April 11, 2018

Press release - Regulatory

Targovax ASA: Protocol from the Annual General Meeting

March 24, 2018

Press release - Regulatory

Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018

March 15, 2018

Press release - Regulatory

Targovax ASA: Notice of Annual General Meeting

March 15, 2018

Press release - Regulatory

Targovax ASA: Annual Report 2017

March 1, 2018

Press release - Regulatory

Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors

February 27, 2018

Press release - Non-regulatory

Targovax to present at Biologics World Nordic 2018

February 15, 2018

Press release - Regulatory

Targovax ASA: Fourth quarter and full year 2017 results

February 7, 2018

Press release - Regulatory

Targovax announces completion of safety lead-in and preliminary immune activation data in ONCOS-102 trial in mesothelioma

February 6, 2018

Press release - Regulatory

Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February

February 2, 2018

Press release - Regulatory

Targovax ASA: Exercise price of options

February 1, 2018

Press release - Regulatory

Targovax ASA issues options to employees

January 8, 2018

Press release - Regulatory

Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

January 4, 2018

Press release - Regulatory